Respiridone for conduct disorder. Low dose Risperdal reduced aggressive behavior in pilot study. Subjects were 20 patients, 5-14 years with conduct disorder (DSM-IV) with aggressive behavior of at least moderate severity. Patients were assessed weekly using the Rating of Aggression Against People and/or Property (RAAPP) scale (1=no aggression; 5=intolerable behavior). Risperidone patients gained more weight than controls (4 kg vs <1 kg). In view of the small sample size, observations of statistically significant reductions in aggression in patient taking Risperidone were remarkable.

Findling R, et al: JAACAP 2000; 39:509-516. Funded by Janssen Research Foundation and other sources.

Fb- here, as always, give the psychopharm strategy biologically normal children are represented to have a disease for purpose of justifying medical, pharmacological treatment, in this case with antipsychotic medication. Again, as throughout biological psychiatry there is only an illusion of a disease on the risk side of the risk/benefit equation while on the treatment or benefit side we have an antipsychotic drug, an extraordinarily dangerous drug. Not only is their no medical or ethical justification to treat, this is a crime.